Eltahir Zakaria, Eisa Alaa A, Keayta Mohamed H, Aljhani Yousif A, Alfaroqui Omar, Jenkins Gareth J
College of Applied Medical Sciences, Department of Clinical Laboratory Sciences, Taibah University, Medina, SAU.
College of Medicine, Translation Clinical Trials Unit, Taibah University, Medina, SAU.
Cureus. 2024 Nov 22;16(11):e74242. doi: 10.7759/cureus.74242. eCollection 2024 Nov.
Background Esophageal cancer is a prevalent and highly lethal malignancy worldwide, comprising two main subtypes: esophageal squamous cell carcinoma (ESCC) and esophageal adenocarcinoma (EAC). While both subtypes are frequently encountered, ESCC has historically been more common globally. However, in recent decades, EAC has emerged as the predominant type in industrialized nations, often developing from Barrett's esophagus, a condition driven by chronic gastroesophageal reflux disease (GERD). ESCC typically occurs in the upper esophagus, whereas EAC arises near the lower gastroesophageal junction. The etiology of esophageal cancer is multifactorial, with diverse causes and clinical management strategies. Notably, diagnosing tumors located in the lower esophagus presents significant challenges. EAC is particularly prone to diagnostic errors, as it can be mistaken for ESCC. This study aims to investigate potential histological biomarkers for EAC to facilitate early and accurate identification of histological changes, especially in patients with GERD. Methods This cross-sectional study examined archival histological samples from patients with lower esophageal abnormalities. Immunohistochemistry was used to investigate the P63 marker, while Masson's trichrome stain was employed to evaluate cancer progression and associated microenvironmental changes. Results A total of 104 cases were analyzed, including 13 with known P63-positive staining and five P63-negative controls. The remaining cases consisted of both precancerous and cancerous tissues diagnosed as EAC. Among these, 86 cases showed negative P63 staining, confirming their origin from non-squamous cells and supporting their classification as true Barrett's-related epithelium. In contrast, five of the 13 SCC control cases exhibited P63 positivity, demonstrating a highly significant association (p < 0.00001). Additionally, Masson's trichrome staining revealed stromal collagen fibers infiltrating the malignant tissue areas. Conclusions This study highlights the significance of the P63 marker in distinguishing between ESCC and EAC. It also suggests a potential role for Masson's trichrome stain in identifying early microenvironmental changes associated with EAC progression.
食管癌是一种在全球范围内普遍存在且致死率很高的恶性肿瘤,主要包括两种亚型:食管鳞状细胞癌(ESCC)和食管腺癌(EAC)。虽然这两种亚型都很常见,但从历史上看,ESCC在全球更为普遍。然而,近几十年来,EAC在工业化国家已成为主要类型,通常由巴雷特食管发展而来,巴雷特食管是一种由慢性胃食管反流病(GERD)引起的疾病。ESCC通常发生在食管上段,而EAC则出现在胃食管交界附近。食管癌的病因是多因素的,有多种病因和临床管理策略。值得注意的是,诊断位于食管下段的肿瘤面临重大挑战。EAC特别容易出现诊断错误,因为它可能被误诊为ESCC。本研究旨在调查EAC的潜在组织学生物标志物,以促进对组织学变化的早期和准确识别,特别是在GERD患者中。方法:这项横断面研究检查了食管下段异常患者的存档组织学样本。免疫组织化学用于研究P63标记物,而Masson三色染色用于评估癌症进展和相关的微环境变化。结果:共分析了104例病例,包括13例已知P63阳性染色病例和5例P63阴性对照。其余病例包括诊断为EAC的癌前组织和癌组织。其中,86例显示P63染色阴性,证实它们起源于非鳞状细胞,并支持将它们分类为真正的巴雷特相关上皮。相比之下,13例SCC对照病例中有5例表现出P63阳性,显示出高度显著的相关性(p < 0.00001)。此外,Masson三色染色显示基质胶原纤维浸润恶性组织区域。结论:本研究强调了P63标记物在区分ESCC和EAC方面的重要性。它还表明Masson三色染色在识别与EAC进展相关的早期微环境变化方面可能发挥的作用。